Rapporteurs : Professeur Bruno levy (Nancy)








télécharger 0.55 Mb.
titreRapporteurs : Professeur Bruno levy (Nancy)
page9/10
date de publication18.11.2017
taille0.55 Mb.
typeRapport
b.21-bal.com > documents > Rapport
1   2   3   4   5   6   7   8   9   10

56. Tate RM, Vanbenthuysen KM, Shasby DM, McMurtry IF, Repine JE. Oxygen-radical-mediated permeability edema and vasoconstriction in isolated perfused rabbit lungs. The American review of respiratory disease. 1982 Nov;126(5):802-6.

57. Baird BR, Cheronis JC, Sandhaus RA, Berger EM, White CW, Repine JE. O2 metabolites and neutrophil elastase synergistically cause edematous injury in isolated rat lungs. J Appl Physiol. 1986 Dec;61(6):2224-9.

58. Kooy NW, Royall JA, Ye YZ, Kelly DR, Beckman JS. Evidence for in vivo peroxynitrite production in human acute lung injury. American journal of respiratory and critical care medicine. 1995 Apr;151(4):1250-4.

59. Baldwin SR, Simon RH, Grum CM, Ketai LH, Boxer LA, Devall LJ. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet. 1986 Jan 4;1(8471):11-4.

60. Gole MD, Souza JM, Choi I, Hertkorn C, Malcolm S, Foust RF, 3rd, et al. Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome. American journal of physiology. 2000 May;278(5):L961-7.

61. Chow CW, Herrera Abreu MT, Suzuki T, Downey GP. Oxidative stress and acute lung injury. American journal of respiratory cell and molecular biology. 2003 Oct;29(4):427-31.

62. Moraes TJ, Chow CW, Downey GP. Proteases and lung injury. Critical care medicine. 2003 Apr;31(4 Suppl):S189-94.

63. Tkalcevic J, Novelli M, Phylactides M, Iredale JP, Segal AW, Roes J. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity. 2000 Feb;12(2):201-10.

64. Donnelly SC, MacGregor I, Zamani A, Gordon MW, Robertson CE, Steedman DJ, et al. Plasma elastase levels and the development of the adult respiratory distress syndrome. American journal of respiratory and critical care medicine. 1995 May;151(5):1428-33.

65. Delclaux C, d'Ortho MP, Delacourt C, Lebargy F, Brun-Buisson C, Brochard L, et al. Gelatinases in epithelial lining fluid of patients with adult respiratory distress syndrome. The American journal of physiology. 1997 Mar;272(3 Pt 1):L442-51.

66. Lacherade JC, Van De Louw A, Planus E, Escudier E, D'Ortho MP, Lafuma C, et al. Evaluation of basement membrane degradation during TNF-alpha-induced increase in epithelial permeability. American journal of physiology. 2001 Jul;281(1):L134-43.

67. Van de Louw A, Jean D, Frisdal E, Cerf C, d'Ortho MP, Baker AH, et al. Neutrophil proteinases in hydrochloric acid- and endotoxin-induced acute lung injury: evaluation of interstitial protease activity by in situ zymography. Laboratory investigation; a journal of technical methods and pathology. 2002 Feb;82(2):133-45.

68. Amat M, Barcons M, Mancebo J, Mateo J, Oliver A, Mayoral JF, et al. Evolution of leukotriene B4, peptide leukotrienes, and interleukin-8 plasma concentrations in patients at risk of acute respiratory distress syndrome and with acute respiratory distress syndrome: mortality prognostic study. Critical care medicine. 2000 Jan;28(1):57-62.

69. Martin TR, Hagimoto N, Nakamura M, Matute-Bello G. Apoptosis and epithelial injury in the lungs. Proceedings of the American Thoracic Society. 2005;2(3):214-20.

70. Albertine KH, Soulier MF, Wang Z, Ishizaka A, Hashimoto S, Zimmerman GA, et al. Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. The American journal of pathology. 2002 Nov;161(5):1783-96.

71. Buccellato LJ, Tso M, Akinci OI, Chandel NS, Budinger GR. Reactive oxygen species are required for hyperoxia-induced Bax activation and cell death in alveolar epithelial cells. The Journal of biological chemistry. 2004 Feb 20;279(8):6753-60.

72. Hattori K, Heissig B, Wu Y, Dias S, Tejada R, Ferris B, et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nature medicine. 2002 Aug;8(8):841-9.

73. Burnham EL, Taylor WR, Quyyumi AA, Rojas M, Brigham KL, Moss M. Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. American journal of respiratory and critical care medicine. 2005 Oct 1;172(7):854-60.

74. Bone RC, Francis PB, Pierce AK. Intravascular coagulation associated with the adult respiratory distress syndrome. The American journal of medicine. 1976 Nov;61(5):585-9.

75. Glusa E. Vascular effects of thrombin. Seminars in thrombosis and hemostasis. 1992;18(3):296-304.

76. Brass LF. Thrombin and platelet activation. Chest. 2003 Sep;124(3 Suppl):18S-25S.

77. Stearns-Kurosawa DJ, Kurosawa S, Mollica JS, Ferrell GL, Esmon CT. The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proceedings of the National Academy of Sciences of the United States of America. 1996 Sep 17;93(19):10212-6.

78. Faust SN, Heyderman RS, Levin M. Coagulation in severe sepsis: a central role for thrombomodulin and activated protein C. Critical care medicine. 2001 Jul;29(7 Suppl):S62-7; discussion S7-8.

79. Rezaie AR. Exosite-dependent regulation of the protein C anticoagulant pathway. Trends in cardiovascular medicine. 2003 Jan;13(1):8-15.

80. Ware LB, Camerer E, Welty-Wolf K, Schultz MJ, Matthay MA. Bench to bedside: targeting coagulation and fibrinolysis in acute lung injury. American journal of physiology. 2006 Sep;291(3):L307-11.

81. Nakstad B, Boye NP, Lyberg T. Procoagulant activities in human alveolar macrophages. European journal of respiratory diseases. 1987 Nov;71(5):459-71.

82. Gross TJ, Simon RH, Sitrin RG. Tissue factor procoagulant expression by rat alveolar epithelial cells. American journal of respiratory cell and molecular biology. 1992 Apr;6(4):397-403.

83. Bastarache JA, Wang L, Geiser T, Wang Z, Albertine KH, Matthay MA, et al. The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor. Thorax. 2007 Jul;62(7):608-16.

84. Jesmin S, Gando S, Matsuda N, Sakuma I, Kobayashi S, Sakuraya F, et al. Temporal changes in pulmonary expression of key procoagulant molecules in rabbits with endotoxin-induced acute lung injury: elevated expression levels of protease-activated receptors. Thrombosis and haemostasis. 2004 Nov;92(5):966-79.

85. Armstead VE, Opentanova IL, Minchenko AG, Lefer AM. Tissue factor expression in vital organs during murine traumatic shock: role of transcription factors AP-1 and NF-kappaB. Anesthesiology. 1999 Dec;91(6):1844-52.

86. Stouthard JM, Levi M, Hack CE, Veenhof CH, Romijn HA, Sauerwein HP, et al. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thrombosis and haemostasis. 1996 Nov;76(5):738-42.

87. Idell S, Peters J, James KK, Fair DS, Coalson JJ. Local abnormalities of coagulation and fibrinolytic pathways that promote alveolar fibrin deposition in the lungs of baboons with diffuse alveolar damage. The Journal of clinical investigation. 1989 Jul;84(1):181-93.

88. Idell S, James KK, Levin EG, Schwartz BS, Manchanda N, Maunder RJ, et al. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. The Journal of clinical investigation. 1989 Aug;84(2):695-705.

89. Fuchs-Buder T, de Moerloose P, Ricou B, Reber G, Vifian C, Nicod L, et al. Time course of procoagulant activity and D dimer in bronchoalveolar fluid of patients at risk for or with acute respiratory distress syndrome. American journal of respiratory and critical care medicine. 1996 Jan;153(1):163-7.

90. Gunther A, Mosavi P, Heinemann S, Ruppert C, Muth H, Markart P, et al. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. American journal of respiratory and critical care medicine. 2000 Feb;161(2 Pt 1):454-62.

91. Gando S, Nanzaki S, Morimoto Y, Kobayashi S, Kemmotsu O. Systemic activation of tissue-factor dependent coagulation pathway in evolving acute respiratory distress syndrome in patients with trauma and sepsis. The Journal of trauma. 1999 Oct;47(4):719-23.

92. Bastarache JA, Wang L, Wang Z, Albertine KH, Matthay MA, Ware LB. Intra-alveolar tissue factor pathway inhibitor is not sufficient to block tissue factor procoagulant activity. American journal of physiology. 2008 May;294(5):L874-81.

93. Enkhbaatar P, Okajima K, Murakami K, Uchiba M, Okabe H, Okabe K, et al. Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide-induced pulmonary vascular injury by inhibiting leukocyte activation. American journal of respiratory and critical care medicine. 2000 Nov;162(5):1752-9.

94. Miller DL, Welty-Wolf K, Carraway MS, Ezban M, Ghio A, Suliman H, et al. Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide. American journal of respiratory cell and molecular biology. 2002 Jun;26(6):650-8.

95. Carraway MS, Welty-Wolf KE, Miller DL, Ortel TL, Idell S, Ghio AJ, et al. Blockade of tissue factor: treatment for organ injury in established sepsis. American journal of respiratory and critical care medicine. 2003 May 1;167(9):1200-9.

96. Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, et al. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. Jama. 2003 Jul 9;290(2):238-47.

97. Laterre PF, Wittebole X, Dhainaut JF. Anticoagulant therapy in acute lung injury. Critical care medicine. 2003 Apr;31(4 Suppl):S329-36.

98. Uchiba M, Okajima K, Murakami K. Effects of various doses of antithrombin III on endotoxin-induced endothelial cell injury and coagulation abnormalities in rats. Thrombosis research. 1998 Mar 1;89(5):233-41.

99. Stangl K, Laule M, Richter C, Stangl V, Koch J, Goktas O, et al. Pulmonary adrenomedullin counteracts deterioration of coronary flow and myocardial performance evoked by pulmonary endothelins in experimental acute respiratory distress syndrome. Critical care medicine. 2001 May;29(5):1027-32.

100. Giebler R, Schmidt U, Koch S, Peters J, Scherer R. Combined antithrombin III and C1-esterase inhibitor treatment decreases intravascular fibrin deposition and attenuates cardiorespiratory impairment in rabbits exposed to Escherichia coli endotoxin. Critical care medicine. 1999 Mar;27(3):597-604.

101. Murakami K, McGuire R, Cox RA, Jodoin JM, Schmalstieg FC, Traber LD, et al. Recombinant antithrombin attenuates pulmonary inflammation following smoke inhalation and pneumonia in sheep. Critical care medicine. 2003 Feb;31(2):577-83.

102. Kipnis E, Guery BP, Tournoys A, Leroy X, Robriquet L, Fialdes P, et al. Massive alveolar thrombin activation in Pseudomonas aeruginosa-induced acute lung injury. Shock (Augusta, Ga. 2004 May;21(5):444-51.

103. Bajzar L, Nesheim ME, Tracy PB. The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent. Blood. 1996 Sep 15;88(6):2093-100.

104. Dhainaut JF, Yan SB, Cariou A, Mira JP. Soluble thrombomodulin, plasma-derived unactivated protein C, and recombinant human activated protein C in sepsis. Critical care medicine. 2002 May;30(5 Suppl):S318-24.

105. Yamamoto K, Loskutoff DJ. Extrahepatic expression and regulation of protein C in the mouse. The American journal of pathology. 1998 Aug;153(2):547-55.

106. Uchiba M, Okajima K, Murakami K, Nawa K, Okabe H, Takatsuki K. Recombinant human soluble thrombomodulin reduces endotoxin-induced pulmonary vascular injury via protein C activation in rats. Thrombosis and haemostasis. 1995 Nov;74(5):1265-70.

107. Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H, et al. Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood. 1996 Jan 15;87(2):642-7.

108. Grey ST, Tsuchida A, Hau H, Orthner CL, Salem HH, Hancock WW. Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester. J Immunol. 1994 Oct 15;153(8):3664-72.

109. White B, Schmidt M, Murphy C, Livingstone W, O'Toole D, Lawler M, et al. Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 monocytic cell line. British journal of haematology. 2000 Jul;110(1):130-4.

110. Sturn DH, Kaneider NC, Feistritzer C, Djanani A, Fukudome K, Wiedermann CJ. Expression and function of the endothelial protein C receptor in human neutrophils. Blood. 2003 Aug 15;102(4):1499-505.

111. Yoshikawa A, Kaido T, Seto S, Katsuura Y, Imamura M. Activated protein C prevents multiple organ injury following extensive hepatectomy in cirrhotic rats. Journal of hepatology. 2000 Dec;33(6):953-60.

112. Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H, et al. Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. The American journal of physiology. 1997 Feb;272(2 Pt 1):L197-202.

113. Ware LB, Matthay MA, Parsons PE, Thompson BT, Januzzi JL, Eisner MD. Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome*. Critical care medicine. 2007 Jun 19.

114. Wang L, Bastarache JA, Wickersham N, Fang X, Matthay MA, Ware LB. Novel role of the human alveolar epithelium in regulating intra-alveolar coagulation. American journal of respiratory cell and molecular biology. 2007 Apr;36(4):497-503.

115. Cheng T, Liu D, Griffin JH, Fernandez JA, Castellino F, Rosen ED, et al. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nature medicine. 2003 Mar;9(3):338-42.

116. Esmon CT. Protein C pathway in sepsis. Annals of medicine. 2002;34(7-8):598-605.

117. Zeng W, Matter WF, Yan SB, Um SL, Vlahos CJ, Liu L. Effect of drotrecogin alfa (activated) on human endothelial cell permeability and Rho kinase signaling. Critical care medicine. 2004 May;32(5 Suppl):S302-8.

118. Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. The Journal of clinical investigation. 1987 Jan;79(1):124-30.

119. Gomi K, Zushi M, Honda G, Kawahara S, Matsuzaki O, Kanabayashi T, et al. Antithrombotic effect of recombinant human thrombomodulin on thrombin-induced thromboembolism in mice. Blood. 1990 Apr 1;75(7):1396-9.

120. Hasegawa N, Kandra TG, Husari AW, Veiss S, Hart WT, Hedgpeth J, et al. The effects of recombinant human thrombomodulin on endotoxin-induced multiple-system organ failure in rats. American journal of respiratory and critical care medicine. 1996 Jun;153(6 Pt 1):1831-7.

121. Uchiba M, Okajima K, Murakami K, Johno M, Okabe H, Takatsuki K. Recombinant thrombomodulin prevents endotoxin-induced lung injury in rats by inhibiting leukocyte activation. The American journal of physiology. 1996 Sep;271(3 Pt 1):L470-5.

122. Uchiba M, Okajima K, Murakami K, Johno M, Mohri M, Okabe H, et al. rhs-TM prevents ET-induced increase in pulmonary vascular permeability through protein C activation. The American journal of physiology. 1997 Oct;273(4 Pt 1):L889-94.

123. Ikeguchi H, Maruyama S, Morita Y, Fujita Y, Kato T, Natori Y, et al. Effects of human soluble thrombomodulin on experimental glomerulonephritis. Kidney international. 2002 Feb;61(2):490-501.

124. Hou B, Eren M, Painter CA, Covington JW, Dixon JD, Schoenhard JA, et al. Tumor necrosis factor alpha activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor kappaB site. The Journal of biological chemistry. 2004 Apr 30;279(18):18127-36.

125. Chapman HA, Jr., Stone OL, Vavrin Z. Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation. The Journal of clinical investigation. 1984 Mar;73(3):806-15.

126. Chapman HA, Yang XL, Sailor LZ, Sugarbaker DJ. Developmental expression of plasminogen activator inhibitor type 1 by human alveolar macrophages. Possible role in lung injury. J Immunol. 1990 Nov 15;145(10):3398-405.

127. Wygrecka M, Markart P, Ruppert C, Kuchenbuch T, Fink L, Bohle RM, et al. Compartment- and cell-specific expression of coagulation and fibrinolysis factors in the murine lung undergoing inhalational versus intravenous endotoxin application. Thrombosis and haemostasis. 2004 Sep;92(3):529-40.

128. Ts'ao C, Ward WF. Plasminogen activator activity in lung and alveolar macrophages of rats exposed to graded single doses of gamma rays to the right hemithorax. Radiation research. 1985 Sep;103(3):393-402.

129. Hardaway RM, Williams CH, Marvasti M, Farias M, Tseng A, Pinon I, et al. Prevention of adult respiratory distress syndrome with plasminogen activator in pigs. Critical care medicine. 1990 Dec;18(12):1413-8.

130. Carley WW, Niedbala MJ, Gerritsen ME. Isolation, cultivation, and partial characterization of microvascular endothelium derived from human lung. American journal of respiratory cell and molecular biology. 1992 Dec;7(6):620-30.

131. Grau GE, de Moerloose P, Bulla O, Lou J, Lei Z, Reber G, et al. Haemostatic properties of human pulmonary and cerebral microvascular endothelial cells. Thrombosis and haemostasis. 1997 Mar;77(3):585-90.

132. Prabhakaran P, Ware LB, White KE, Cross MT, Matthay MA, Olman MA. Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. American journal of physiology. 2003 Jul;285(1):L20-8.

133. Moalli R, Doyle JM, Tahhan HR, Hasan FM, Braman SS, Saldeen T. Fibrinolysis in critically ill patients. The American review of respiratory disease. 1989 Aug;140(2):287-93.

134. Groeneveld AB, Kindt I, Raijmakers PG, Hack CE, Thijs LG. Systemic coagulation and fibrinolysis in patients with or at risk for the adult respiratory distress syndrome. Thrombosis and haemostasis. 1997 Dec;78(6):1444-9.

135. Levi M, van der Poll T, ten Cate H, van Deventer SJ. The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. European journal of clinical investigation. 1997 Jan;27(1):3-9.

136. van der Poll T, Levi M, Hack CE, ten Cate H, van Deventer SJ, Eerenberg AJ, et al. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. The Journal of experimental medicine. 1994 Apr 1;179(4):1253-9.

137. van der Poll T, Buller HR, ten Cate H, Wortel CH, Bauer KA, van Deventer SJ, et al. Activation of coagulation after administration of tumor necrosis factor to normal subjects. The New England journal of medicine. 1990 Jun 7;322(23):1622-7.

138. van der Poll T, Levi M, van Deventer SJ, ten Cate H, Haagmans BL, Biemond BJ, et al. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees. Blood. 1994 Jan 15;83(2):446-51.

139. Conway EM, Rosenberg RD. Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Molecular and cellular biology. 1988 Dec;8(12):5588-92.

140. van der Poll T, Levi M, Buller HR, van Deventer SJ, de Boer JP, Hack CE, et al. Fibrinolytic response to tumor necrosis factor in healthy subjects. The Journal of experimental medicine. 1991 Sep 1;174(3):729-32.

141. Faust SN, Levin M, Harrison OB, Goldin RD, Lockhart MS, Kondaveeti S, et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. The New England journal of medicine. 2001 Aug 9;345(6):408-16.

142. Nawroth PP, Handley DA, Esmon CT, Stern DM. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proceedings of the National Academy of Sciences of the United States of America. 1986 May;83(10):3460-4.

143. Takano S, Kimura S, Ohdama S, Aoki N. Plasma thrombomodulin in health and diseases. Blood. 1990 Nov 15;76(10):2024-9.

144. Glaser CB, Morser J, Clarke JH, Blasko E, McLean K, Kuhn I, et al. Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation. The Journal of clinical investigation. 1992 Dec;90(6):2565-73.

145. Camerer E, Gjernes E, Wiiger M, Pringle S, Prydz H. Binding of factor VIIa to tissue factor on keratinocytes induces gene expression. The Journal of biological chemistry. 2000 Mar 3;275(9):6580-5.

146. Esmon CT. The interactions between inflammation and coagulation. British journal of haematology. 2005 Nov;131(4):417-30.

147. Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Critical care medicine. 2003 Apr;31(4 Suppl):S213-20.

148. Altieri DC, Etingin OR, Fair DS, Brunck TK, Geltosky JE, Hajjar DP, et al. Structurally homologous ligand binding of integrin Mac-1 and viral glycoprotein C receptors. Science (New York, NY. 1991 Nov 22;254(5035):1200-2.

149. Yamauchi T, Umeda F, Inoguchi T, Nawata H. Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells. Biochemical and biophysical research communications. 1989 Sep 29;163(3):1404-11.

150. Souter PJ, Thomas S, Hubbard AR, Poole S, Romisch J, Gray E. Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood. Critical care medicine. 2001 Jan;29(1):134-9.

151. Oelschlager C, Romisch J, Staubitz A, Stauss H, Leithauser B, Tillmanns H, et al. Antithrombin III inhibits nuclear factor kappaB activation in human monocytes and vascular endothelial cells. Blood. 2002 Jun 1;99(11):4015-20.

152. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. The New England journal of medicine. 2001 Mar 8;344(10):699-709.

153. Yuksel M, Okajima K, Uchiba M, Horiuchi S, Okabe H. Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappa B and activator protein-1 in human monocytes. Thrombosis and haemostasis. 2002 Aug;88(2):267-73.

154. Myles T, Nishimura T, Yun TH, Nagashima M, Morser J, Patterson AJ, et al. Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation. The Journal of biological chemistry. 2003 Dec 19;278(51):51059-67.

155. Campbell W, Okada N, Okada H. Carboxypeptidase R is an inactivator of complement-derived inflammatory peptides and an inhibitor of fibrinolysis. Immunological reviews. 2001 Apr;180:162-7.

156. Fourrier F, Chopin C, Huart JJ, Runge I, Caron C, Goudemand J. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest. 1993 Sep;104(3):882-8.

157. Inthorn D, Hoffmann JN, Hartl WH, Muhlbayer D, Jochum M. Antithrombin III supplementation in severe sepsis: beneficial effects on organ dysfunction. Shock (Augusta, Ga. 1997 Nov;8(5):328-34.

158. Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. Jama. 2001 Oct 17;286(15):1869-78.

159. Wiedermann CJ, Hoffmann JN, Juers M, Ostermann H, Kienast J, Briegel J, et al. High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety. Critical care medicine. 2006 Feb;34(2):285-92.

160. Walters DV, Olver RE. The role of catecholamines in lung liquid absorption at birth. Pediatric research. 1978 Mar;12(3):239-42.

161. Matthay MA, Landolt CC, Staub NC. Differential liquid and protein clearance from the alveoli of anesthetized sheep. J Appl Physiol. 1982 Jul;53(1):96-104.

162. Goodman BE, Crandall ED. Dome formation in primary cultured monolayers of alveolar epithelial cells. The American journal of physiology. 1982 Jul;243(1):C96-100.

163. Matthay MA, Folkesson HG, Clerici C. Lung epithelial fluid transport and the resolution of pulmonary edema. Physiological reviews. 2002 Jul;82(3):569-600.

164. Matalon S, Benos DJ, Jackson RM. Biophysical and molecular properties of amiloride-inhibitable Na+ channels in alveolar epithelial cells. The American journal of physiology. 1996 Jul;271(1 Pt 1):L1-22.

165. Matthay MA, Folkesson HG, Verkman AS. Salt and water transport across alveolar and distal airway epithelia in the adult lung. The American journal of physiology. 1996 Apr;270(4 Pt 1):L487-503.

166. Basset G, Crone C, Saumon G. Fluid absorption by rat lung in situ: pathways for sodium entry in the luminal membrane of alveolar epithelium. The Journal of physiology. 1987 Mar;384:325-45.

167. Canessa CM, Schild L, Buell G, Thorens B, Gautschi I, Horisberger JD, et al. Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits. Nature. 1994 Feb 3;367(6462):463-7.

168. Hummler E, Barker P, Gatzy J, Beermann F, Verdumo C, Schmidt A, et al. Early death due to defective neonatal lung liquid clearance in alpha-ENaC-deficient mice. Nature genetics. 1996 Mar;12(3):325-8.

169. Mutlu GM, Sznajder JI. Mechanisms of pulmonary edema clearance. American journal of physiology. 2005 Nov;289(5):L685-95.

170. Song Y, Fukuda N, Bai C, Ma T, Matthay MA, Verkman AS. Role of aquaporins in alveolar fluid clearance in neonatal and adult lung, and in oedema formation following acute lung injury: studies in transgenic aquaporin null mice. The Journal of physiology. 2000 Jun 15;525 Pt 3:771-9.

171. Dobbs LG, Gonzalez R, Matthay MA, Carter EP, Allen L, Verkman AS. Highly water-permeable type I alveolar epithelial cells confer high water permeability between the airspace and vasculature in rat lung. Proceedings of the National Academy of Sciences of the United States of America. 1998 Mar 17;95(6):2991-6.

172. Ridge KM, Rutschman DH, Factor P, Katz AI, Bertorello AM, Sznajder JL. Differential expression of Na-K-ATPase isoforms in rat alveolar epithelial cells. The American journal of physiology. 1997 Jul;273(1 Pt 1):L246-55.

173. Matthay MA, Berthiaume Y, Staub NC. Long-term clearance of liquid and protein from the lungs of unanesthetized sheep. J Appl Physiol. 1985 Sep;59(3):928-34.

174. Serikov VB, Grady M, Matthay MA. Effect of temperature on alveolar liquid and protein clearance in an in situ perfused goat lung. J Appl Physiol. 1993 Aug;75(2):940-7.

175. Rutschman DH, Olivera W, Sznajder JI. Active transport and passive liquid movement in isolated perfused rat lungs. J Appl Physiol. 1993 Oct;75(4):1574-80.

176. Sakuma T, Okaniwa G, Nakada T, Nishimura T, Fujimura S, Matthay MA. Alveolar fluid clearance in the resected human lung. American journal of respiratory and critical care medicine. 1994 Aug;150(2):305-10.

177. Goodman BE, Brown SE, Crandall ED. Regulation of transport across pulmonary alveolar epithelial cell monolayers. J Appl Physiol. 1984 Sep;57(3):703-10.

178. Norlin A, Folkesson HG. Alveolar fluid clearance in late-gestational guinea pigs after labor induction: mechanisms and regulation. American journal of physiology. 2001 Apr;280(4):L606-16.

179. Berthiaume Y, Staub NC, Matthay MA. Beta-adrenergic agonists increase lung liquid clearance in anesthetized sheep. The Journal of clinical investigation. 1987 Feb;79(2):335-43.

180. Sakuma T, Folkesson HG, Suzuki S, Okaniwa G, Fujimura S, Matthay MA. Beta-adrenergic agonist stimulated alveolar fluid clearance in ex vivo human and rat lungs. American journal of respiratory and critical care medicine. 1997 Feb;155(2):506-12.

181. Goodman BE, Anderson JL, Clemens JW. Evidence for regulation of sodium transport from airspace to vascular space by cAMP. The American journal of physiology. 1989 Aug;257(2 Pt 1):L86-93.

182. Mutlu GM, Dumasius V, Burhop J, McShane PJ, Meng FJ, Welch L, et al. Upregulation of alveolar epithelial active Na+ transport is dependent on beta2-adrenergic receptor signaling. Circulation research. 2004 Apr 30;94(8):1091-100.

183. Pittet JF, Wiener-Kronish JP, McElroy MC, Folkesson HG, Matthay MA. Stimulation of lung epithelial liquid clearance by endogenous release of catecholamines in septic shock in anesthetized rats. The Journal of clinical investigation. 1994 Aug;94(2):663-71.

184. Laffon M, Jayr C, Barbry P, Wang Y, Folkesson HG, Pittet JF, et al. Lidocaine induces a reversible decrease in alveolar epithelial fluid clearance in rats. Anesthesiology. 2002 Feb;96(2):392-9.

185. Yue G, Russell WJ, Benos DJ, Jackson RM, Olman MA, Matalon S. Increased expression and activity of sodium channels in alveolar type II cells of hyperoxic rats. Proceedings of the National Academy of Sciences of the United States of America. 1995 Aug 29;92(18):8418-22.

186. Minakata Y, Suzuki S, Grygorczyk C, Dagenais A, Berthiaume Y. Impact of beta-adrenergic agonist on Na+ channel and Na+-K+-ATPase expression in alveolar type II cells. The American journal of physiology. 1998 Aug;275(2 Pt 1):L414-22.

187. Snyder PM. Liddle's syndrome mutations disrupt cAMP-mediated translocation of the epithelial Na(+) channel to the cell surface. The Journal of clinical investigation. 2000 Jan;105(1):45-53.

188. Stutts MJ, Canessa CM, Olsen JC, Hamrick M, Cohn JA, Rossier BC, et al. CFTR as a cAMP-dependent regulator of sodium channels. Science (New York, NY. 1995 Aug 11;269(5225):847-50.

189. Jiang X, Ingbar DH, O'Grady SM. Adrenergic stimulation of Na+ transport across alveolar epithelial cells involves activation of apical Cl- channels. The American journal of physiology. 1998 Dec;275(6 Pt 1):C1610-20.

190. Reddy MM, Light MJ, Quinton PM. Activation of the epithelial Na+ channel (ENaC) requires CFTR Cl- channel function. Nature. 1999 Nov 18;402(6759):301-4.

191. Engelhardt JF, Zepeda M, Cohn JA, Yankaskas JR, Wilson JM. Expression of the cystic fibrosis gene in adult human lung. The Journal of clinical investigation. 1994 Feb;93(2):737-49.

192. Fang X, Fukuda N, Barbry P, Sartori C, Verkman AS, Matthay MA. Novel role for CFTR in fluid absorption from the distal airspaces of the lung. The Journal of general physiology. 2002 Feb;119(2):199-207.

193. Lei J, Nowbar S, Mariash CN, Ingbar DH. Thyroid hormone stimulates Na-K-ATPase activity and its plasma membrane insertion in rat alveolar epithelial cells. American journal of physiology. 2003 Sep;285(3):L762-72.

194. Guery BP, Mason CM, Dobard EP, Beaucaire G, Summer WR, Nelson S. Keratinocyte growth factor increases transalveolar sodium reabsorption in normal and injured rat lungs. American journal of respiratory and critical care medicine. 1997 May;155(5):1777-84.

195. Guo Y, DuVall MD, Crow JP, Matalon S. Nitric oxide inhibits Na+ absorption across cultured alveolar type II monolayers. The American journal of physiology. 1998 Mar;274(3 Pt 1):L369-77.

196. Sloniewsky DE, Ridge KM, Adir Y, Fries FP, Briva A, Sznajder JI, et al. Leukotriene D4 activates alveolar epithelial Na,K-ATPase and increases alveolar fluid clearance. American journal of respiratory and critical care medicine. 2004 Feb 1;169(3):407-12.

197. Planes C, Leyvraz C, Uchida T, Angelova MA, Vuagniaux G, Hummler E, et al. In vitro and in vivo regulation of transepithelial lung alveolar sodium transport by serine proteases. American journal of physiology. 2005 Jun;288(6):L1099-109.

198. Barnard ML, Olivera WG, Rutschman DM, Bertorello AM, Katz AI, Sznajder JI. Dopamine stimulates sodium transport and liquid clearance in rat lung epithelium. American journal of respiratory and critical care medicine. 1997 Sep;156(3 Pt 1):709-14.

199. Tibayan FA, Chesnutt AN, Folkesson HG, Eandi J, Matthay MA. Dobutamine increases alveolar liquid clearance in ventilated rats by beta-2 receptor stimulation. American journal of respiratory and critical care medicine. 1997 Aug;156(2 Pt 1):438-44.

200. Tohda H, Marunaka Y. Insulin-activated amiloride-blockable nonselective cation and Na+ channels in the fetal distal lung epithelium. General pharmacology. 1995 Jul;26(4):755-63.

201. Wu BJ, Hulbert AJ, Storlien LH, Else PL. Membrane lipids and sodium pumps of cattle and crocodiles: an experimental test of the membrane pacemaker theory of metabolism. Am J Physiol Regul Integr Comp Physiol. 2004 Sep;287(3):R633-41.

202. Pierre M, Husson MO, Le Berre R, Desseyn JL, Galabert C, Beghin L, et al. Omega-3 polyunsaturated fatty acids improve host response in chronic Pseudomonas aeruginosa lung infection in mice. American journal of physiology. 2007 Jun;292(6):L1422-31.

203. Else PL, Wu BJ, Storlien LH, Hulbert AJ. Molecular activity of Na+,K+-ATPase relates to the packing of membrane lipids. Annals of the New York Academy of Sciences. 2003 Apr;986:525-6.

204. Hulbert AJ, Else PL. Membranes as possible pacemakers of metabolism. Journal of theoretical biology. 1999 Aug 7;199(3):257-74.

205. Brigham KL, Meyrick B. Endotoxin and lung injury. The American review of respiratory disease. 1986 May;133(5):913-27.

206. Brigham KL, Woolverton WC, Blake LH, Staub NC. Increased sheep lung vascular permeability caused by pseudomonas bacteremia. The Journal of clinical investigation. 1974 Oct;54(4):792-804.

207. Pittet JF, Brenner TJ, Modelska K, Matthay MA. Alveolar liquid clearance is increased by endogenous catecholamines in hemorrhagic shock in rats. J Appl Physiol. 1996 Aug;81(2):830-7.

208. Lane SM, Maender KC, Awender NE, Maron MB. Adrenal epinephrine increases alveolar liquid clearance in a canine model of neurogenic pulmonary edema. American journal of respiratory and critical care medicine. 1998 Sep;158(3):760-8.

209. Wiener-Kronish JP, Sakuma T, Kudoh I, Pittet JF, Frank D, Dobbs L, et al. Alveolar epithelial injury and pleural empyema in acute P. aeruginosa pneumonia in anesthetized rabbits. J Appl Physiol. 1993 Oct;75(4):1661-9.

210. Pittet JF, Matthay MA, Pier G, Grady M, Wiener-Kronish JP. Pseudomonas aeruginosa-induced lung and pleural injury in sheep. Differential protective effect of circulating versus alveolar immunoglobulin G antibody. The Journal of clinical investigation. 1993 Sep;92(3):1221-8.

211. Sawa T, Yahr TL, Ohara M, Kurahashi K, Gropper MA, Wiener-Kronish JP, et al. Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury. Nature medicine. 1999 Apr;5(4):392-8.

212. Hickman-Davis JM, McNicholas-Bevensee C, Davis IC, Ma HP, Davis GC, Bosworth CA, et al. Reactive species mediate inhibition of alveolar type II sodium transport during mycoplasma infection. American journal of respiratory and critical care medicine. 2006 Feb 1;173(3):334-44.

213. Pittet JF, Hashimoto S, Pian M, McElroy MC, Nitenberg G, Wiener-Kronish JP. Exotoxin A stimulates fluid reabsorption from distal airspaces of lung in anesthetized rats. The American journal of physiology. 1996 Feb;270(2 Pt 1):L232-41.

214. Garat C, Rezaiguia S, Meignan M, D'Ortho MP, Harf A, Matthay MA, et al. Alveolar endotoxin increases alveolar liquid clearance in rats. J Appl Physiol. 1995 Dec;79(6):2021-8.

215. Rezaiguia S, Garat C, Delclaux C, Meignan M, Fleury J, Legrand P, et al. Acute bacterial pneumonia in rats increases alveolar epithelial fluid clearance by a tumor necrosis factor-alpha-dependent mechanism. The Journal of clinical investigation. 1997 Jan 15;99(2):325-35.

216. Berthiaume Y. Tumor necrosis factor and lung edema clearance: the tip of the iceberg? American journal of respiratory and critical care medicine. 2003 Nov 1;168(9):1022-3.

217. Fukuda N, Jayr C, Lazrak A, Wang Y, Lucas R, Matalon S, et al. Mechanisms of TNF-alpha stimulation of amiloride-sensitive sodium transport across alveolar epithelium. American journal of physiology. 2001 Jun;280(6):L1258-65.

218. Dehler M, Zessin E, Bartsch P, Mairbaurl H. Hypoxia causes permeability oedema in the constant-pressure perfused rat lung. Eur Respir J. 2006 Mar;27(3):600-6.

219. Planes C, Friedlander G, Loiseau A, Amiel C, Clerici C. Inhibition of Na-K-ATPase activity after prolonged hypoxia in an alveolar epithelial cell line. The American journal of physiology. 1996 Jul;271(1 Pt 1):L70-8.

220. Suzuki S, Noda M, Sugita M, Ono S, Koike K, Fujimura S. Impairment of transalveolar fluid transport and lung Na(+)-K(+)-ATPase function by hypoxia in rats. J Appl Physiol. 1999 Sep;87(3):962-8.

221. Vivona ML, Matthay M, Chabaud MB, Friedlander G, Clerici C. Hypoxia reduces alveolar epithelial sodium and fluid transport in rats: reversal by beta-adrenergic agonist treatment. American journal of respiratory cell and molecular biology. 2001 Nov;25(5):554-61.

222. Lecuona E, Saldias F, Comellas A, Ridge K, Guerrero C, Sznajder JI. Ventilator-associated lung injury decreases lung ability to clear edema in rats. American journal of respiratory and critical care medicine. 1999 Feb;159(2):603-9.

223. Frank JA, Gutierrez JA, Jones KD, Allen L, Dobbs L, Matthay MA. Low tidal volume reduces epithelial and endothelial injury in acid-injured rat lungs. American journal of respiratory and critical care medicine. 2002 Jan 15;165(2):242-9.

224. Frank JA, Pittet JF, Lee H, Godzich M, Matthay MA. High tidal volume ventilation induces NOS2 and impairs cAMP- dependent air space fluid clearance. American journal of physiology. 2003 May;284(5):L791-8.

225. Frank JA, Wray CM, McAuley DF, Schwendener R, Matthay MA. Alveolar macrophages contribute to alveolar barrier dysfunction in ventilator-induced lung injury. American journal of physiology. 2006 Dec;291(6):L1191-8.

226. Vadasz I, Morty RE, Olschewski A, Konigshoff M, Kohstall MG, Ghofrani HA, et al. Thrombin impairs alveolar fluid clearance by promoting endocytosis of Na+,K+-ATPase. American journal of respiratory cell and molecular biology. 2005 Oct;33(4):343-54.

227. Khimenko PL, Barnard JW, Moore TM, Wilson PS, Ballard ST, Taylor AE. Vascular permeability and epithelial transport effects on lung edema formation in ischemia and reperfusion. J Appl Physiol. 1994 Sep;77(3):1116-21.

228. Frank JA, Wang Y, Osorio O, Matthay MA. Beta-adrenergic agonist therapy accelerates the resolution of hydrostatic pulmonary edema in sheep and rats. J Appl Physiol. 2000 Oct;89(4):1255-65.

229. McGraw DW, Fukuda N, James PF, Forbes SL, Woo AL, Lingrel JB, et al. Targeted transgenic expression of beta(2)-adrenergic receptors to type II cells increases alveolar fluid clearance. American journal of physiology. 2001 Oct;281(4):L895-903.

230. Sartori C, Matthay MA. Alveolar epithelial fluid transport in acute lung injury: new insights. Eur Respir J. 2002 Nov;20(5):1299-313.

231. Matthay MA, Wiener-Kronish JP. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. The American review of respiratory disease. 1990 Dec;142(6 Pt 1):1250-7.

232. Verghese GM, Ware LB, Matthay BA, Matthay MA. Alveolar epithelial fluid transport and the resolution of clinically severe hydrostatic pulmonary edema. J Appl Physiol. 1999 Oct;87(4):1301-12.

233. Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. American journal of respiratory and critical care medicine. 2001 May;163(6):1376-83.

234. Pugin J, Verghese G, Widmer MC, Matthay MA. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Critical care medicine. 1999 Feb;27(2):304-12.

235. Ware LB, Golden JA, Finkbeiner WE, Matthay MA. Alveolar epithelial fluid transport capacity in reperfusion lung injury after lung transplantation. American journal of respiratory and critical care medicine. 1999 Mar;159(3):980-8.

236. Sartori C, Allemann Y, Duplain H, Lepori M, Egli M, Lipp E, et al. Salmeterol for the prevention of high-altitude pulmonary edema. The New England journal of medicine. 2002 May 23;346(21):1631-6.

237. Perkins GD, McAuley DF, Thickett DR, Gao F. The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. American journal of respiratory and critical care medicine. 2006 Feb 1;173(3):281-7.

238. Olivera W, Ridge K, Wood LD, Sznajder JI. ANF decreases active sodium transport and increases alveolar epithelial permeability in rats. J Appl Physiol. 1993 Oct;75(4):1581-6.

239. Mutlu GM, Adir Y, Jameel M, Akhmedov AT, Welch L, Dumasius V, et al. Interdependency of beta-adrenergic receptors and CFTR in regulation of alveolar active Na+ transport. Circulation research. 2005 May 13;96(9):999-1005.

240. Dagenais A, Frechette R, Clermont ME, Masse C, Prive A, Brochiero E, et al. Dexamethasone inhibits the action of TNF on ENaC expression and activity. American journal of physiology. 2006 Dec;291(6):L1220-31.

241. Hunter WM, Greenwood FC. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495-6.

242. Ernst EJ, Hashimoto S, Guglielmo J, Sawa T, Pittet JF, Kropp H, et al. Effects of antibiotic therapy on Pseudomonas aeruginosa-induced lung injury in a rat model. Antimicrobial agents and chemotherapy. 1999 Oct;43(10):2389-94.

243. Fukuda N, Folkesson HG, Matthay MA. Relationship of interstitial fluid volume to alveolar fluid clearance in mice: ventilated vs. in situ studies. J Appl Physiol. 2000 Aug;89(2):672-9.

244. Taylor FB, Jr. Studies on the inflammatory-coagulant axis in the baboon response to E. coli: regulatory roles of proteins C, S, C4bBP and of inhibitors of tissue factor. Progress in clinical and biological research. 1994;388:175-94.

245. Maybauer MO, Maybauer DM, Fraser JF, Traber LD, Westphal M, Enkhbaatar P, et al. Recombinant human activated protein C improves pulmonary function in ovine acute lung injury resulting from smoke inhalation and sepsis. Critical care medicine. 2006 Sep;34(9):2432-8.

246. Dhainaut JF, Laterre PF, Janes JM, Bernard GR, Artigas A, Bakker J, et al. Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial. Intensive care medicine. 2003 Jun;29(6):894-903.

247. Nick JA, Coldren CD, Geraci MW, Poch KR, Fouty BW, O'Brien J, et al. Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood. 2004 Dec 15;104(13):3878-85.

248. Liu KD, Levitt J, Zhuo H, Kallet RH, Brady S, Steingrub J, et al. Randomized clinical trial of activated protein C for the treatment of acute lung injury. American journal of respiratory and critical care medicine. 2008 Sep 15;178(6):618-23.

249. Richard JC, Bregeon F, Leray V, Le Bars D, Costes N, Tourvieille C, et al. Effect of activated protein C on pulmonary blood flow and cytokine production in experimental acute lung injury. Intensive care medicine. 2007 Dec;33(12):2199-206.

250. Pittet JF, Wiener-Kronish JP, Serikov V, Matthay MA. Resistance of the alveolar epithelium to injury from septic shock in sheep. American journal of respiratory and critical care medicine. 1995 Apr;151(4):1093-100.

251. Le Berre R, Faure K, Fauvel H, Viget NB, Ader F, Prangere T, et al. Apoptosis inhibition in P. aeruginosa-induced lung injury influences lung fluid balance. Intensive care medicine. 2004 Jun;30(6):1204-11.

252. McGee MP, Rothberger H. Tissue factor in bronchoalveolar lavage fluids. Evidence for an alveolar macrophage source. The American review of respiratory disease. 1985 Mar;131(3):331-6.

253. Chan AK, Berry L, Mitchell L, Baranowski B, O'Brodovich H, Andrew M. Effect of a novel covalent antithrombin-heparin complex on thrombin generation on fetal distal lung epithelium. The American journal of physiology. 1998 Jun;274(6 Pt 1):L914-21.

254. Modelska K, Matthay MA, McElroy MC, Pittet JF. Upregulation of alveolar liquid clearance after fluid resuscitation for hemorrhagic shock in rats. The American journal of physiology. 1997 Aug;273(2 Pt 1):L305-14.

255. Chen XJ, Seth S, Yue G, Kamat P, Compans RW, Guidot D, et al. Influenza virus inhibits ENaC and lung fluid clearance. American journal of physiology. 2004 Aug;287(2):L366-73.

256. Abraham E, Arcaroli J, Shenkar R. Activation of extracellular signal-regulated kinases, NF-kappa B, and cyclic adenosine 5'-monophosphate response element-binding protein in lung neutrophils occurs by differing mechanisms after hemorrhage or endotoxemia. J Immunol. 2001 Jan 1;166(1):522-30.

257. Adkins WK, Barnard JW, May S, Seibert AF, Haynes J, Taylor AE. Compounds that increase cAMP prevent ischemia-reperfusion pulmonary capillary injury. J Appl Physiol. 1992 Feb;72(2):492-7.

258. Minnear FL, DeMichele MA, Moon DG, Rieder CL, Fenton JW, 2nd. Isoproterenol reduces thrombin-induced pulmonary endothelial permeability in vitro. The American journal of physiology. 1989 Nov;257(5 Pt 2):H1613-23.

259. Liu F, Verin AD, Borbiev T, Garcia JG. Role of cAMP-dependent protein kinase A activity in endothelial cell cytoskeleton rearrangement. American journal of physiology. 2001 Jun;280(6):L1309-17.

260. Patterson CE, Lum H, Schaphorst KL, Verin AD, Garcia JG. Regulation of endothelial barrier function by the cAMP-dependent protein kinase. Endothelium. 2000;7(4):287-308.

261. Basran GS, Hardy JG, Woo SP, Ramasubramanian R, Byrne AJ. Beta-2-adrenoceptor agonists as inhibitors of lung vascular permeability to radiolabelled transferrin in the adult respiratory distress syndrome in man. European journal of nuclear medicine. 1986;12(8):381-4.

262. Spengler RN, Allen RM, Remick DG, Strieter RM, Kunkel SL. Stimulation of alpha-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J Immunol. 1990 Sep 1;145(5):1430-4.

263. Izeboud CA, Monshouwer M, van Miert AS, Witkamp RF. The beta-adrenoceptor agonist clenbuterol is a potent inhibitor of the LPS-induced production of TNF-alpha and IL-6 in vitro and in vivo. Inflamm Res. 1999 Sep;48(9):497-502.

264. Maris NA, de Vos AF, Dessing MC, Spek CA, Lutter R, Jansen HM, et al. Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. American journal of respiratory and critical care medicine. 2005 Oct 1;172(7):878-84.

265. van der Poll T, Coyle SM, Barbosa K, Braxton CC, Lowry SF. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. The Journal of clinical investigation. 1996 Feb 1;97(3):713-9.

266. Lalli E, Sassone-Corsi P. Signal transduction and gene regulation: the nuclear response to cAMP. The Journal of biological chemistry. 1994 Jul 1;269(26):17359-62.

267. Lefkowitz RJ, Caron MG, Stiles GL. Mechanisms of membrane-receptor regulation. Biochemical, physiological, and clinical insights derived from studies of the adrenergic receptors. The New England journal of medicine. 1984 Jun 14;310(24):1570-9.

268. Doe S, Woods B, Perks AM. Effects of norepinephrine on lung liquid production by in vitro lungs from fetal guinea pigs. Canadian journal of physiology and pharmacology. 1998 Oct-Nov;76(10-11):967-74.

269. Higuchi M, Murata Y, Miyake Y, Hesser J, Tyner J, Keegan KA, et al. Effects of norepinephrine on lung fluid flow rate in the chronically catheterized fetal lamb. American journal of obstetrics and gynecology. 1987 Oct;157(4 Pt 1):986-90.

270. Azzam ZS, Adir Y, Crespo A, Comellas A, Lecuona E, Dada LA, et al. Norepinephrine increases alveolar fluid reabsorption and Na,K-ATPase activity. American journal of respiratory and critical care medicine. 2004 Oct 1;170(7):730-6.

271. Norlin A, Finley N, Abedinpour P, Folkesson HG. Alveolar liquid clearance in the anesthetized ventilated guinea pig. The American journal of physiology. 1998 Feb;274(2 Pt 1):L235-43.

272. Sakuma T, Tuchihara C, Ishigaki M, Osanai K, Nambu Y, Toga H, et al. Denopamine, a beta(1)-adrenergic agonist, increases alveolar fluid clearance in ex vivo rat and guinea pig lungs. J Appl Physiol. 2001 Jan;90(1):10-6.

273. Gu X, Wang Z, Xu J, Maeda S, Sugita M, Sagawa M, et al. Denopamine stimulates alveolar fluid clearance via cystic fibrosis transmembrane conductance regulator in rat lungs. Respirology (Carlton, Vic. 2006 Sep;11(5):566-71.

274. Sakuma T, Tuchihara C, Ishigaki M, Osanai K, Nambu Y, Toga H, et al. Beta1-adrenoceptor stimulation by high-dose terbutaline downregulates terbutaline-stimulated alveolar fluid clearance in ex vivo rat lung. Experimental lung research. 2001 Jul-Aug;27(5):453-68.

275. Suzuki S, Zuege D, Berthiaume Y. Sodium-independent modulation of Na(+)-K(+)-ATPase activity by beta-adrenergic agonist in alveolar type II cells. The American journal of physiology. 1995 Jun;268(6 Pt 1):L983-90.

276. Naren AP, Cobb B, Li C, Roy K, Nelson D, Heda GD, et al. A macromolecular complex of beta 2 adrenergic receptor, CFTR, and ezrin/radixin/moesin-binding phosphoprotein 50 is regulated by PKA. Proceedings of the National Academy of Sciences of the United States of America. 2003 Jan 7;100(1):342-6.

277. Taouil K, Hinnrasky J, Hologne C, Corlieu P, Klossek JM, Puchelle E. Stimulation of beta 2-adrenergic receptor increases cystic fibrosis transmembrane conductance regulator expression in human airway epithelial cells through a cAMP/protein kinase A-independent pathway. The Journal of biological chemistry. 2003 May 9;278(19):17320-7.

278. Charron PD, Fawley JP, Maron MB. Effect of epinephrine on alveolar liquid clearance in the rat. J Appl Physiol. 1999 Aug;87(2):611-8.

279. Modelska K, Matthay MA, Brown LA, Deutch E, Lu LN, Pittet JF. Inhibition of beta-adrenergic-dependent alveolar epithelial clearance by oxidant mechanisms after hemorrhagic shock. The American journal of physiology. 1999 May;276(5 Pt 1):L844-57.

280. Lasnier JM, Wangensteen OD, Schmitz LS, Gross CR, Ingbar DH. Terbutaline stimulates alveolar fluid resorption in hyperoxic lung injury. J Appl Physiol. 1996 Oct;81(4):1723-9.

281. Saldias FJ, Lecuona E, Comellas AP, Ridge KM, Rutschman DH, Sznajder JI. beta-adrenergic stimulation restores rat lung ability to clear edema in ventilator-associated lung injury. American journal of respiratory and critical care medicine. 2000 Jul;162(1):282-7.

282. McAuley DF, Frank JA, Fang X, Matthay MA. Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury. Critical care medicine. 2004 Jul;32(7):1470-6.

283. Maron MB. Dose-response relationship between plasma epinephrine concentration and alveolar liquid clearance in dogs. J Appl Physiol. 1998 Nov;85(5):1702-7.

284. Sakuma T, Gu X, Wang Z, Maeda S, Sugita M, Sagawa M, et al. Stimulation of alveolar epithelial fluid clearance in human lungs by exogenous epinephrine. Critical care medicine. 2006 Mar;34(3):676-81.

285. Atabai K, Ware LB, Snider ME, Koch P, Daniel B, Nuckton TJ, et al. Aerosolized beta(2)-adrenergic agonists achieve therapeutic levels in the pulmonary edema fluid of ventilated patients with acute respiratory failure. Intensive care medicine. 2002 Jun;28(6):705-11.

1   2   3   4   5   6   7   8   9   10

similaire:

Rapporteurs : Professeur Bruno levy (Nancy) iconRapporteurs
«kmp girls» qui se reconnaitront ici et à Bruno Delépine qui me fait l’honneur de participer au jury de la thèse

Rapporteurs : Professeur Bruno levy (Nancy) iconAdresse générique
«Université de Lorraine» qui a été créé par fusion des universités de Nancy 1, Nancy 2, Metz et de l’inpl (Institut national polytechnique...

Rapporteurs : Professeur Bruno levy (Nancy) iconTHÈse présentée à Nancy

Rapporteurs : Professeur Bruno levy (Nancy) iconAdam bruno / chiss robert / kaiser andré 4 micholet isabelle

Rapporteurs : Professeur Bruno levy (Nancy) iconUniversite paris XI- aix-marseille II – lyon I nancy I

Rapporteurs : Professeur Bruno levy (Nancy) iconRapporteurs

Rapporteurs : Professeur Bruno levy (Nancy) iconRapporteurs

Rapporteurs : Professeur Bruno levy (Nancy) iconRapporteurs

Rapporteurs : Professeur Bruno levy (Nancy) iconRapporteurs

Rapporteurs : Professeur Bruno levy (Nancy) iconRapporteurs : Pr Lysiane Richert








Tous droits réservés. Copyright © 2016
contacts
b.21-bal.com